MARC details
| 000 -LEADER |
|---|
| fixed length control field |
05402cam a2200577Ia 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
ocn821115168 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20221128212050.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION |
|---|
| fixed length control field |
m d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr mn||||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
121213s2013 si a ob 001 0 eng d |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
HKP |
| 019 ## - |
|---|
| -- |
902865034 |
| -- |
1086433884 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| ISBN |
9789814368674 |
| Qualifying information |
(electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| ISBN |
9814368679 |
| Qualifying information |
(electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| Cancelled/invalid ISBN |
9789814368667 |
| Qualifying information |
(print) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| Cancelled/invalid ISBN |
9814368660 |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
516998 |
| -- |
(N$T) |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(OCoLC)821115168 |
| Canceled/invalid control number |
(OCoLC)902865034 |
| -- |
(OCoLC)1086433884 |
| 060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
QV 778 |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
MED |
| Subject category code subdivision |
023000 |
| Source |
bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
MED |
| Subject category code subdivision |
058170 |
| Source |
bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
MED |
| Subject category code subdivision |
071000 |
| Source |
bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
MED |
| Subject category code subdivision |
072000 |
| Source |
bisacsh |
| 049 ## - LOCAL HOLDINGS (OCLC) |
|---|
| Holding library |
MAIN |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Nanopharmaceutics : |
| Subtitle |
the potential application of nanomaterials |
| Statement of responsibility, etc |
|
| Medium |
[E-Book] |
| 260 ## - PUBLICATION INFORMATION |
|---|
| Place of publication |
Singapore : |
| Publisher |
World Scientific Pub. Co., |
| Date |
2013. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Physical description |
1 online resource (ix, 594 pages) : |
| Other physical details |
illustrations (some color) |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
computer |
| Media type code |
c |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
online resource |
| Carrier type code |
cr |
| Source |
rdacarrier |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 520 ## - ABSTRACT |
|---|
| Abstract |
Nanomaterials, with their unique size-dependent physical and chemical properties, have shown promising advantages as drug and gene delivery vehicles, ultra-sensitive intracellular detectors and novel therapeutic drugs. Nanopharmaceutics is one of the disciplines that will benefit the most from this technology. Nanotechnology will have a revolutionary impact on cancer diagnosis and therapy due to the exceptional characteristics of nanopharmaceutics. This book provides an overview of some tools, methods, and materials of nanotechnology that offer potential applications in pharmaceutics, followed by a series of examples showing applications that are already in development. It may very well inspire researchers to develop a new generation of pharmaceutics with inventive non-traditional approach and employ nanoscale science for the benefit of the patient. |
| 505 0# - CONTENTS |
|---|
| Contents |
Ch. 1. Innovative treatments for cancer: the impact of delivering siRNAs, chemotherapies, and preventative agents using nanoformulations / Sara S. Hook [and others] -- ch. 2. Nano-emulsions: overview and applications / Xiang Li, Nicolas Anton and Thierry Vandamme -- ch. 3. Protein nanopharmaceuticals -- Concepts and safety considerations / Eva Horn Moller, Lene Jorgensen and Natalie J. Medlicott -- ch. 4. Nanoscaled proteomic analysis / Yan Xu and Lee Jia -- ch. 5. Tumor targeting potential of Lipid-Based Nano-Pharmaceuticals (LNPs) / Kshitij Gupta [and others] -- ch. 6. Novel methods of lipidic nanoparticle preparation and drug loading / Yoshie M. -- ch. 7. Biomedical properties study of modified chitosan nanoparticles for drug delivery systems / Mohammad Reza Saboktakin -- ch. 8. Dendrimers as nanovectors for nucleic acid delivery / Xiaoxuan Liu, Qi Wang, Ling Peng -- ch. 9. Drug delivery systems for platinum drugs / Vien T. Huynh, Wei Scarano, Martina H. Stenzel -- ch. 10. Improving platinum efficiency: nanoformulations / Rolando Carmona and Xing-Jie Liang -- ch. 11. Design principles of nanoparticles as contrast agents for magnetic resonance imaging / Liang Shan, Xinbin Gu, Paul Wang -- ch. 12. Perfluorocarbon nanoparticles: a theranostic platform technology / G.M. Lanza [and others] -- ch. 13. Potential toxic effects of nano-oxides / Mingsheng Xu [and others] -- ch. 14. Electron spin resonance spectroscopy for studying the generation and scavenging of reactive oxygen species by nanomaterials / Jun-Jie Yin [and others] -- ch. 15. Nanotechnology: a new approach to improve orthopedic implants / Hongjian Zhou, Fangfang Sun, Jaebeom Lee -- ch. 16. In situ controlled release of dopamine for treatment of Parkinson's Disease -- ch. 17. Novel nanotechnology strategies for the treatment and prevention of HIV infection / Jian Jun Tan [and others] -- ch. 18. Interaction of nanoparticles with the immune system and their significance in drug-design and development / Anil Kumar, Bhargavi M. Boruah and Xing-Jie Liang -- ch. 19. Nano-carbon-based systems for the delivery of bioactive agents: pros and cons / Tapas R. Nayak and Giorgia Pastorin -- ch. 20. Nanostructures with biocompatible and biodegradable characteristics / Jie Meng. |
| 590 ## - LOCAL NOTE (RLIN) |
|---|
| Local note |
WorldCat record variable field(s) change: 650 |
| 650 #0 - SUBJECT HEADINGS |
|---|
| Subject term |
Nanomedicine. |
| 650 #0 - SUBJECT HEADINGS |
|---|
| Subject term |
Nanoparticles. |
| 650 #0 - SUBJECT HEADINGS |
|---|
| Subject term |
Nanotechnology. |
| 650 #2 - SUBJECT HEADINGS |
|---|
| Subject term |
Nanomedicine |
| 650 #2 - SUBJECT HEADINGS |
|---|
| Subject term |
Nanoparticles |
| 700 1# - ADDED PERSONAL NAME |
|---|
| Added personal author |
Liang, Xing-Jie. |
| 856 40 - ONLINE RESOURCE |
|---|
| Uniform Resource Identifier |
<a href="https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=516998">https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=516998</a> |
| Link text |
Kingston Hospital NHS Foundation Trust OpenAthens account holders click here for access |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Suppress in OPAC |
Do not Suppress in OPAC |
| 938 ## - |
|---|
| -- |
Askews and Holts Library Services |
| -- |
ASKH |
| -- |
AH24926162 |
| 938 ## - |
|---|
| -- |
Coutts Information Services |
| -- |
COUT |
| -- |
24464883 |
| 938 ## - |
|---|
| -- |
ebrary |
| -- |
EBRY |
| -- |
ebr10640618 |
| 938 ## - |
|---|
| -- |
EBSCOhost |
| -- |
EBSC |
| -- |
516998 |
| 938 ## - |
|---|
| -- |
ProQuest MyiLibrary Digital eBook Collection |
| -- |
IDEB |
| -- |
cis24464883 |
| 938 ## - |
|---|
| -- |
YBP Library Services |
| -- |
YANK |
| -- |
9961400 |
| 994 ## - |
|---|
| -- |
92 |
| -- |
N$T |